MoneyWorks4Me

The revenue zoomed 12.10% to Rs. 605.97 millions for the quarter ended June 2022 as compared to Rs. 540.55 millions during the corresponding quarter last year.A big loss of -94.61% reported for the quarter ended June 2022 to Rs. 3.69  millions from Rs. 68.50 millions.Operating profit for the quarter ended June 2022 decreased to 67.31 millions as compared to 100.97 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 605.97 540.55 12.10 605.97 540.55 12.10 2260.97 1879.46 20.30
Other Income 3.13 8.22 -61.92 3.13 8.22 -61.92 33.36 43.93 -24.06
PBIDT 67.31 100.97 -33.34 67.31 100.97 -33.34 291.31 234.72 24.11
Interest 0.14 1.05 -86.67 0.14 1.05 -86.67 2.85 5.14 -44.55
PBDT 9.13 99.92 -90.86 9.13 99.92 -90.86 288.46 229.58 25.65
Depreciation 1.93 2.83 -31.80 1.93 2.83 -31.80 15.26 10.86 40.52
PBT 7.20 97.09 -92.58 7.20 97.09 -92.58 273.20 218.72 24.91
TAX 3.51 28.59 -87.72 3.51 28.59 -87.72 77.32 48.14 60.61
Deferred Tax -4.68 0.13 -3700.00 -4.68 0.13 -3700.00 0.00 0.00 0.00
PAT 3.69 68.50 -94.61 3.69 68.50 -94.61 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 11.11 18.68 -40.53 11.11 18.68 -40.53 12.88 12.49 3.17
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..